Latka logo

Lucida Medical Revenue (2024)

Lucida Medical generated an estimated $615.8K in annual revenue in 2024. Source: GetLatka estimate

SaaS, Cancer Diagnosis, Radiology, MRI, Prostate Cancer

Last updated

Lucida Medical Revenue

In 2024, Lucida Medical's revenue reached $615.8K. The company previously reported $486.8K in 2023. Since its launch in 2019, Lucida Medical has shown consistent revenue growth.

Lucida Medical Revenue GrowthReported revenue / ARR over time · latest figure estimated$0$150K$300K$450K$600K$750K201920202021202220232024$0$382.7K$486.8K$615.8KSource: GetLatka.com
YearMilestoneSource
2024Lucida Medical Hit $615.8k revenue in October 2024Estimated
2023Lucida Medical Hit $486.8k revenue in October 2023Estimated
2021Lucida Medical Hit $382.7k revenue in April 2021Not recorded
2019Launched with $0 revenue

Founder / CEO

We don't have Lucida Medical's Founder / CEO on record yet.

Lucida Medical Employees & Team Size

Lucida Medical employs approximately 17 people as of 2026.

Lucida Medical Team GrowthReported headcount over time048121620201920202021202220232024001717Source: GetLatka.com
YearMilestoneSource
2024Reached 17 employees (October 2024)Not recorded
2023Reached 17 employees (October 2023)Not recorded
2022Reached 16 employees (October 2022)Not recorded
2021Reached 16 employees (December 2021)Not recorded
2021Reached 5 employees (April 2021)Not recorded

Frequently Asked Questions about Lucida Medical

What is Lucida Medical's revenue?

As of 2024, Lucida Medical generated an estimated $615.8K in annual revenue.

When was Lucida Medical founded?

Lucida Medical was founded in 2019.

How many employees does Lucida Medical have?

As of 2024, Lucida Medical had 17 employees.

Where is Lucida Medical headquartered?

Lucida Medical is headquartered in Cambridge, England, United Kingdom.

Compare Lucida Medical to the industry

Lucida Medical operates across multiple industries. Browse revenue, funding, and growth data for Lucida Medical in each sector below.

Data and Sources

All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.

Claim this profile